Trials@uspto.gov
`Tel: 571-272-7822
`
`
`Paper 63
`Entered: June 16, 2014
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`GNOSIS S.P.A., GNOSIS BIORESEARCH S.A., and GNOSIS U.S.A., INC.
`Petitioners
`
`v.
`
`SOUTH ALABAMA MEDICAL SCIENCE FOUNDATION and MERCK & CIE
`Patent Owners
`_______________
`
`Case IPR2013-00116 (Patent 5,997,915)
`Case IPR2013-00117 (Patent 6,011,040)
`Case IPR2013-00118 (Patent 6,673,381)
`Case IPR2013-00119 (Patent 7,172,778)1
`
`
`
`
`
`
`
`
`Before JACQUELINE WRIGHT BONILLA, SCOTT E. KAMHOLZ, and
`SHERIDAN K. SNEDDEN, Administrative Patent Judges.
`
`
`KAMHOLZ, Administrative Patent Judge.
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`1 South Alabama Medical Science Foundation (“SAMSF”) is the Patent
`Owner in cases IPR2013-00116, -00117, and -00119. Merck & Cie
`(“Merck”) is the Patent Owner in case IPR2013-00117.
`
`

`

`IPR2013-00116; IPR2013-00117;
`IPR2013-00118; IPR2013-00119
`
`
`
`By email dated May 13, 2014 (copy attached), Gnosis requested
`correction of several errors in the oral argument transcript. Patent Owners
`oppose most of the corrections, because they regard the challenged passages
`as not appearing, on their face, to be transcriptional errors.
`Upon review of the proposed corrections, we determine that none of
`them is sufficiently substantial to warrant formal correction of the oral
`argument transcript. The parties’ positions on the proposed corrections are
`noted in the record.
`Accordingly, it is
`ORDERED that Petitioners’ request for correction of the oral
`argument transcript is denied.
`
`
`
`
`
`
`
`2
`
`

`

`IPR2013-00116; IPR2013-00117;
`IPR2013-00118; IPR2013-00119
`
`
`For PETITIONERS:
`
`Jonathan J. Krit
`Janine A. Moderson
`Amin Talati, LLC
`
`Joseph E. Cwik
`Erik B. Flom
`Husch Blackwell LLP
`
`For PATENT OWNERS:
`
`Thomas Parker
`Jitendra Malik
`Alston & Bird, LLP
`
`(SAMSF)
`Peter Rogalskyj
`The Law Office of Peter Rogalskyj
`
`(Merck)
`Anthony J. Zelano
`Brion P. Heaney
`Millen, White, Zelano & Branigan, P.C.
`
`
`
`3
`
`

`

`IPR2013-00116; IPR2013-00117;
`IPR2013-00118; IPR2013-00119
`
`
`______________________________________________________________________________
`From: Cwik, Joseph [mailto:Joseph.Cwik@huschblackwell.com]
`Sent: Tuesday, May 13, 2014 5:31 PM
`To: Trials
`Cc: thomas.parker@alston.com; Sterling, Andrew (Andrew.Sterling@alston.com); Malik, Jitty
`(Jitty.Malik@alston.com); Peter Rogalskyj (pr@prpatent.com) (pr@prpatent.com); 'Tony Zelano'
`(Zelano@mwzb.com); Brion Heaney (heaney@mwzb.com) (heaney@mwzb.com)
`Subject: IPR2013-00116, IPR2013-00117, IPR2013-00118, and IPR2013-00119
`
`
`Dear PTAB:
`
`
`We are counsel for Petitioners in the above-listed four IPRs.
`
`
`We write to report several likely transcription errors in the transcript of the
`Oral Hearing held on March 20, 2014. Case IPR2013-00116, Paper 64;
`Case IPR2013-00117, Paper 67; Case IPR2013-00118, Paper 60; Case
`IPR2013-00119, Paper 61.
`
`
`On May 9, 2014, the Board allowed Patent Owner to correct a similar error
`in the transcript after the court reporter checked the corresponding audio
`file. See, Case IPR2013-00116, Paper 65; Case IPR2013-00117, Paper 68;
`Case IPR2013-00118, Paper 61; Case IPR2013-00119, Paper 61.
`
`
`Because the Board was willing to correct an error for Patent Owners,
`Petitioners also request that the audio file be checked for the following
`additional errors below:
`
`
`On page 66, ln. 20-23, the transcript states, “Table 4 of Exhibit 1019
`contains data that clearly is showing the folate deficiency is created by 5-
`MTHF, and it's doing this through administration over 60 days, and it's not
`reporting any of the concerns that Dr. Gregory raised.” As is evident from
`Table 4 of Exhibit 1019 itself, Petitioners request that the incorrect word
`“created” be replaced by the word “treated.”
`
`
`On page 71, ln. 17 -18, the transcript states "he wrote -- well, the article he
`wrote was about the potential of a folinic acid for being a successful
`treatment of DPN." As is evident from the referenced Exhibit 1130,
`Petitioners request that the incorrect word “folinic” be replaced by the
`correct word “alpa-lipoic.”
`
`
`
`
`4
`
`

`

`IPR2013-00116; IPR2013-00117;
`IPR2013-00118; IPR2013-00119
`
`
`On page 75, ln. 15, the transcript states "He refers to folic preparations and
`not folic acid" Petitioners request the incorrect phrase “folic preparations”
`be replaced with the correct phrase “folate preparations.”
`
`
`On page 139, ln. 19, the transcript states, "discussing -- in its description of
`the heartbeat reference, but there are." Petitioners request the incorrect word
`“heartbeat” be replaced with the correct word “Harpey.”
`
`
`On page 141, ln. 17 and 19-20, the transcript states "calcium gluconate." As
`is evident from the Exhibit 1016, Petitioners request that the incorrect phrase
`“calcium gluconate” be replaced with correct phrase “calcium leucovorin.”
`
`
`Petitioners seek guidance from the Board regarding how Petitioners may
`correct these additional transcription errors.
`
`
`Petitioners raised this matter with Patent Owners, who indicated that
`“Petitioners’ requests refer to changes which, on their face, do not appear to
`be transcriptional errors, with the exception of replacing the word ‘heartbeat’
`with ‘Harpey.’ Therefore, Patent Owners have no objection to Petitioners’
`request to replace ‘heartbeat’ with ‘Harpey.’ Patent Owners do, however,
`object to Petitioners’ remaining requested changes to the record.”
`
`Joseph E. Cwik
`Partner
`
`
`HUSCH BLACKWELL LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, IL 60606-3912
`Direct: 312.526.1622
`Fax: 312.655.1501
`Joseph.Cwik@huschblackwell.com
`
`huschblackwell.com
`View Bio | View VCard
`2013.
`
`
`
`Named a top healthcare law firm by American Health Lawyers Association and Modern Healthcare in
`
`Any tax advice contained in or attached to this message or email string is not intended or
`written to be used, and cannot be used to (i) avoid penalties that may be imposed on any
`taxpayer under the Internal Revenue Code or (ii) promote, market, or recommend to
`another any transaction addressed herein.
`
`
`
`
`
`5
`
`